INSM

INSMED Inc

INSMED Inc (INSM) has 9 SEC Form 4 filings (50 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Jul 10, 2026.

The most active filer is Chief Medical Officer Flammer Martina M.D. with 6 filings. Insiders have net sold $8.0M over the trailing 6 months.

  • Industry:Biotechnology
  • CEO:William H. Lewis
  • Employees:1,271
  • HQ:Bridgewater, NJ, US
  • IPO:2000-06-01

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$37.8M

reported sales (SEC code S)

Unique Insiders

3

in the rolling window

Market Cap

$23.3B

latest known value

Source
Sale$1.3MJul 10SEC ↗
Sale$1.4MJul 8SEC ↗
Lewis WilliamFirst in 5 months
Sale$2.2MJun 26SEC ↗
Sale$173KJun 24SEC ↗
Flammer Martina M.D.First in 4 months
Sale$1.3MMay 13SEC ↗
Lewis WilliamFirst filing
Sale$1.7MJan 22SEC ↗
Flammer Martina M.D.First in 4 months
Sale$1.8MJan 8SEC ↗
Flammer Martina M.D.First in 4 months
Sale$252KJan 8SEC ↗
Flammer Martina M.D.First in 4 months
Sale$855KJan 8SEC ↗
Sale$26.9MSep 4SEC ↗

Congress trading INSM

See timeline →
  • DRep. Josh GottheimerSale$1,001 - $15,0002026-06-10

STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.

Related companies

INSMED Inc is in the Healthcare sector.